As of Feb 27
| -0.04 / -1.51%|
The 3 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +53.26% increase from the last price of 2.61.
The current consensus among 3 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.